Cita APA (7a ed.)
Liu, K., Huang, L., Jiang, G., Guo, N., Tan, Q., Cai, Y., . . . Jia, J. (2026). Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer. Clinical Medicine Insights: Oncology, 20, 1-9.
Cita Chicago Style (17a ed.)
Liu, Ke-Jun, et al. "Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer." Clinical Medicine Insights: Oncology 20 (2026): 1-9.
Cita MLA (9a ed.)
Liu, Ke-Jun, et al. "Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer." Clinical Medicine Insights: Oncology, vol. 20, 2026, pp. 1-9.
Precaución: Estas citas no son 100% exactas.